THC Farmaceuticals, Inc. (CBDG)
USD 0.01
(8.0%)
USD 0.01
(8.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -14.97 Thousand USD | -103.51% |
| 2022 | 426.9 Thousand USD | 5170.13% |
| 2021 | -8420.00 USD | 86.07% |
| 2020 | -60.44 Thousand USD | 87.88% |
| 2019 | -498.56 Thousand USD | -3170.36% |
| 2018 | -15.24 Thousand USD | -108.84% |
| 2017 | -7300.00 USD | 94.64% |
| 2016 | -136.11 Thousand USD | 0.0% |
| 2014 | -30.70 USD | -28.78% |
| 2013 | -23.84 USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2022 Q3 | -3163.00 USD | 43.89% |
| 2022 Q1 | -844.00 USD | 0.0% |
| 2022 Q2 | -5637.00 USD | -567.89% |
| 2021 FY | -8420.00 USD | 86.07% |
| 2020 FY | -60.44 Thousand USD | 87.88% |
| 2020 Q1 | 57.77 Thousand USD | 0.0% |
| 2019 Q3 | -443.93 Thousand USD | -2021.25% |
| 2019 FY | -498.56 Thousand USD | -3170.36% |
| 2019 Q2 | -20.92 Thousand USD | 0.0% |
| 2018 FY | -15.24 Thousand USD | -108.84% |
| 2017 FY | -7300.00 USD | 94.64% |
| 2016 FY | -136.11 Thousand USD | 0.0% |
| 2015 Q2 | -19.80 USD | -132.57% |
| 2015 Q1 | -8.51 USD | 1.24% |
| 2015 Q3 | -35.69 USD | -80.24% |
| 2014 Q2 | -3.63 USD | 74.43% |
| 2014 Q1 | -14.19 USD | -225.33% |
| 2014 FY | -30.70 USD | -28.78% |
| 2014 Q4 | -8.62 USD | -102.75% |
| 2014 Q3 | -4.25 USD | -17.13% |
| 2013 FY | -23.84 USD | 0.0% |
| 2013 Q2 | -2.62 USD | 0.0% |
| 2013 Q3 | -5.28 USD | -101.6% |
| 2013 Q4 | -4.36 USD | 17.37% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1.33 Million USD | 98.879% |
| Arch Therapeutics, Inc. | -6.98 Million USD | 99.786% |
| Evofem Biosciences, Inc. | 52.97 Million USD | 100.028% |
| Nascent Biotech, Inc. | -2.08 Million USD | 99.283% |
| Rebus Holdings, Inc. | -1.02 Million USD | 98.532% |
| Santhera Pharmaceuticals Holding AG | 65.13 Million USD | 100.023% |
| Qrons Inc. | -789.34 Thousand USD | 98.103% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | -632.4 Thousand USD | 97.632% |
| Northwest Biotherapeutics, Inc. | -62.59 Million USD | 99.976% |
| ProtoKinetix, Incorporated | -415.47 Thousand USD | 96.395% |
| Skye Bioscience, Inc. | -37.64 Million USD | 99.96% |
| Eiger BioPharmaceuticals, Inc. | -74.96 Million USD | 99.98% |
| Nanobac Pharmaceuticals, Incorporated | -6.57 Million USD | 99.772% |
| Institute of Biomedical Research Corp. | -273.4 Thousand USD | 94.522% |
| SQZ Biotechnologies Company | -79.46 Million USD | 99.981% |
| Intellipharmaceutics International Inc. | -2.89 Million USD | 99.482% |
| Propanc Biopharma, Inc. | -1.82 Million USD | 99.177% |
| Mesoblast Limited | -87.95 Million USD | 99.983% |
| Marizyme, Inc. | -65.34 Million USD | 99.977% |
| Genus plc | 7.9 Million USD | 100.19% |
| VioQuest Pharmaceuticals, Inc. | -10.89 Million USD | 99.863% |
| Pharming Group N.V. | -10.54 Million USD | 99.858% |
| Therapeutic Solutions International, Inc. | -2.16 Million USD | 99.31% |
| CNBX Pharmaceuticals Inc. | -3.71 Million USD | 99.596% |
| Nymox Pharmaceutical Corporation | -8.84 Million USD | 99.831% |
| ContraFect Corporation | -65.15 Million USD | 99.977% |
| PsyBio Therapeutics Corp. | -4.88 Million USD | 99.693% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | -1.72 Million USD | 99.133% |
| IMV Inc. | -36.48 Million USD | 99.959% |
| AXIM Biotechnologies, Inc. | -8.05 Million USD | 99.814% |
| MultiCell Technologies, Inc. | -380.07 USD | -3840.327% |
| ONE Bio Corp. | 8.67 Million USD | 100.173% |
| Accustem Sciences Inc. | -3.74 Million USD | 99.6% |
| RVL Pharmaceuticals plc | -51.69 Million USD | 99.971% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | -1.26 Million USD | 98.818% |
| Q BioMed Inc. | -2.05 Million USD | 99.27% |
| Emmaus Life Sciences, Inc. | -3.73 Million USD | 99.599% |
| Mosaic ImmunoEngineering Inc. | -2.38 Million USD | 99.371% |
| Biomind Labs Inc. | -1.21 Million USD | 98.767% |
| American Oriental Bioengineering, Inc. | -59.72 Million USD | 99.975% |
| Provectus Biopharmaceuticals, Inc. | -3.1 Million USD | 99.517% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | -7.9 Million USD | 99.811% |
| GlobeStar Therapeutics Corporation | -1.94 Million USD | 99.232% |
| Acro Biomedical Co., Ltd. | -15.87 Million USD | 99.906% |
| Curative Biotechnology, Inc. | -5.81 Million USD | 99.743% |
| GB Sciences, Inc. | -1.36 Million USD | 98.9% |
| Alpha Cognition Inc. | -13.77 Million USD | 99.891% |
| HST Global, Inc. | -146.21 Thousand USD | 89.757% |
| CSL Limited | 2.64 Billion USD | 100.001% |
| Wesana Health Holdings Inc. | -1.75 Million USD | 99.147% |
| Halberd Corporation | -79.67 Thousand USD | 81.204% |
| Enzolytics Inc. | -2.17 Million USD | 99.312% |
| Agentix Corp. | -1.37 Million USD | 98.91% |
| Resverlogix Corp. | -3.61 Million USD | 99.585% |
| Nuo Therapeutics, Inc. | -3.17 Million USD | 99.528% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -295.05 Million USD | 99.995% |
| Enzon Pharmaceuticals, Inc. | 98 Thousand USD | 115.282% |
| Endonovo Therapeutics, Inc. | 6.92 Million USD | 100.216% |
| RespireRx Pharmaceuticals Inc. | -3.97 Million USD | 99.623% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -3.02 Million USD | 99.505% |
| AVAX Technologies, Inc. | -6.41 Million USD | 99.766% |
| Zenith Capital Corp. | -10.59 Million USD | 99.859% |
| Genscript Biotech Corporation | -95.47 Million USD | 99.984% |
| Ember Therapeutics, Inc. | -23.24 Thousand USD | 35.565% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | -4.14 Million USD | 99.639% |
| WPD Pharmaceuticals Inc. | -60.44 Thousand USD | 75.222% |
| Cotinga Pharmaceuticals Inc. | -2 Million USD | 99.253% |
| Kadimastem Ltd | -3.3 Million USD | 99.547% |
| Helix BioMedix, Inc. | -1.05 Million USD | 98.582% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | -3.81 Million USD | 99.608% |
| BioStem Technologies, Inc. | -8.48 Million USD | 99.823% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | -441.36 Thousand USD | 96.607% |
| LadRx Corporation | 400.44 Thousand USD | 103.74% |
| Cell Source, Inc. | -5.32 Million USD | 99.719% |
| Regen BioPharma, Inc. | 1.02 Million USD | 101.463% |
| Regen BioPharma, Inc. | 1.02 Million USD | 101.463% |
| NovAccess Global Inc. | -4.76 Million USD | 99.686% |
| Affymax, Inc. | -14.42 Million USD | 99.896% |
| Itoco Inc. | -1.86 Million USD | 99.199% |
| Rasna Therapeutics, Inc. | -4.44 Million USD | 99.663% |
| Pathfinder Cell Therapy, Inc. | -1.66 Million USD | 99.103% |
| Mobile Lads Corp. | -2.26 Million USD | 99.338% |
| CytoDyn Inc. | -49.84 Million USD | 99.97% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -79.03 Thousand USD | 81.051% |
| NanoSphere Health Sciences Inc. | -228.12 Thousand USD | 93.435% |
| Alseres Pharmaceuticals, Inc. | -941.52 Thousand USD | 98.409% |
| SYBLEU INC | -180.3 Thousand USD | 91.694% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | -1.61 Million USD | 99.071% |
| International Stem Cell Corporation | -131 Thousand USD | 88.568% |
| Bioxytran, Inc. | -4.28 Million USD | 99.65% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | -54.27 Thousand USD | 72.406% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | -2.53 Million USD | 99.408% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | -48.07 Million USD | 99.969% |
| Adhera Therapeutics, Inc. | -2.11 Million USD | 99.292% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | -780.88 Thousand USD | 98.082% |
| Innovation Pharmaceuticals Inc. | -3.16 Million USD | 99.527% |
| Neutra Corp. | -233.46 Thousand USD | 93.585% |
| Windtree Therapeutics, Inc. | -20.29 Million USD | 99.926% |
| PureTech Health plc | -65.69 Million USD | 99.977% |
| Coeptis Therapeutics, Inc. | -21.26 Million USD | 99.93% |
| IXICO plc | -1.17 Million USD | 98.729% |
| IntelGenx Technologies Corp. | -9.92 Million USD | 99.849% |
| Gelesis Holdings, Inc. | -57.12 Million USD | 99.974% |
| CSL Limited | 2.64 Billion USD | 100.001% |
| Cellectis S.A. | -103.17 Million USD | 99.985% |